Quris.AI
Quris.AI is transforming drug safety prediction by uniquely combining advanced AI capabilities with cutting edge 3D organ models, enabling predictions with unprecedented accuracy and scalability. our platform has been extensively validated by leading Pharma companies, including a long term collaboration with Merck GmbH. By predicting safety in human relevant 3D models, our platform significantly increases the likelihood of clinical success and reduces significantly the need for animal testing.
CanChip GmbH
We are a commercial provider of a microphysiological system either as a product or service.
Assessment of drug-induced toxicity biomarkers in the brain microphysiological system (MPS) using targeted and untargeted molecular profiling
Application of a skin and liver Chip2 microphysiological model to investigate the route-dependent toxicokinetics and toxicodynamics of consumer-relevant doses of genistein
High content analysis of in vitro alveolar macrophage responses can provide mechanistic insight for inhaled product safety assessment
Microphysiological system for assessing drug-induced liver toxicity in vitro
TheWell Bioscience
TheWell Bioscience provides xeno-free, 3D cell culture solutions, empowering research in organoids, regenerative medicine, and drug discovery.
VoxCell BioInnovation
VoxCell BioInnovation is a forward-thinking biotechnology company specializing in 3D, vascularized bioprinted tissue models for preclinical drug screening. Using high-resolution bioprinting, trade vascularization software, and Universal Bioinks™, VoxCell creates human-like tumor models that mimic the tumor microenvironment, enhancing drug testing accuracy.
Optics11
Optics11Life develops cutting-edge life science tools using optical fiber sensing technology. The two main products are: The Nanoindentation Platform (Pavone, Piuma and Chiaro) and The Cuore 3D Engineered Muscle Contractility Platform